Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,251 to #4,300.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Sica A, et al. J. Clin. Invest (2012) cited as Ref 453 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  2. Hao NB, et al. Clin. Dev. Immunol. (2012) cited as Ref 454 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  3. Medrek C, et al. BMC Cancer (2012) cited as Ref 455 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  4. Yamaguchi T, et al. Gastric Cancer (2016) cited as Ref 456 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  5. Zhou P, et al. Mol. Cancer (2017) cited as Ref 457 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  6. Yang Z, et al. Oncotarget (2016) cited as Ref 458 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  7. Huang WC, et al. Oncotarget (2016) cited as Ref 459 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  8. Masahisa J, et al. Proc. Natl Acad. Sci. USA (2011) cited as Ref 460 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  9. Wu A, et al. Neuro Oncol. (2010) cited as Ref 461 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  10. Yi L, et al. J. Neuroimmunol. (2011) cited as Ref 462 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  11. Yamashina T, et al. Cancer Res. (2014) cited as Ref 463 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:07, 20 May 2020)
  12. Leslie CS, et al. Nat. Med. (2013) cited as Ref 464 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  13. Shi Y, et al. Nat. Commun. (2017) cited as Ref 465 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  14. Xie K, et al. Cytokine Growth Factor Rev. (2001) cited as Ref 466 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  15. Yang J, et al. Stem Cells (2013) cited as Ref 467 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  16. Fu XT, et al. Int. J. Oncol. (2015) cited as Ref 468 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  17. Wang H, et al. Cell Oncol. (Dordr.) (2016) cited as Ref 469 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  18. Kalluri R, et al. Nat. Rev. Cancer (2006) cited as Ref 470 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  19. Potenta S, et al. Br. J. Cancer (2008) cited as Ref 471 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  20. Crisan M, et al. Cell Stem Cell (2008) cited as Ref 472 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  21. Kalluri R, et al. J. Clin. Invest (2009) cited as Ref 473 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  22. Buchsbaum RJ, et al. Cancers (2016) cited as Ref 474 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  23. Jotzu C, et al. Cell. Oncol. (2011) cited as Ref 475 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  24. Wikstrom P, et al. Prostate (2009) cited as Ref 476 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  25. Goicoechea SM, et al. Oncogene (2014) cited as Ref 477 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  26. Xia L, et al. Carcinogenesis (2014) cited as Ref 478 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  27. Nair N, et al. Sci. Rep. (2017) cited as Ref 479 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  28. Scheel C, et al. Cell (2011) cited as Ref 480 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  29. Giannoni E, et al. Cancer Res. (2010) cited as Ref 481 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  30. Liao CP, et al. Cancer Res. (2010) cited as Ref 482 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  31. Wolfson B, et al. World J. Biol. Chem. (2015) cited as Ref 483 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  32. Chaffer CL, et al. Cell (2013) cited as Ref 484 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  33. Chen WJ, et al. Nat. Commun. (2014) cited as Ref 485 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  34. Tsuyada A, et al. Cancer Res. (2012) cited as Ref 486 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  35. Giordano C, et al. Oncotarget (2016) cited as Ref 487 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  36. Mccuaig R, et al. Pathology (2016) cited as Ref 488 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  37. Lau EY, et al. Cell Rep. (2016) cited as Ref 489 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  38. Xiong S, et al. Am. J. Cancer Res. (2018) cited as Ref 490 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  39. Yibing H, et al. PLoS ONE (2015) cited as Ref 491 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  40. Cavarretta IT, et al. Mol. Ther. (2010) cited as Ref 493 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  41. Bagley RG, et al. Int. J. Oncol. (2009) cited as Ref 492 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  42. Kidd S, et al. Stem Cells (2009) cited as Ref 494 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  43. Martin FT, et al. Breast Cancer Res. Treat. (2010) cited as Ref 495 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  44. Xue J, et al. BMC Cancer (2015) cited as Ref 496 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  45. Hanahan D, et al. Cell (2011) cited as Ref 497 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  46. Brunel M, et al. Curr. Transplant. Rep. (2016) cited as Ref 498 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  47. Abdel AMT, et al. J. Exp. Clin. Cancer Res. (2011) cited as Ref 499 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  48. Maffey A, et al. Sci. Rep. (2017) cited as Ref 500 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  49. Tu B, et al. Cancer Lett. (2012) cited as Ref 501 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)
  50. Spaeth EL, et al. PLoS ONE (2013) cited as Ref 502 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:08, 20 May 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)